SEC Form 4 · accession 0001209191-16-100275
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred D Kingsley
Director
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 8:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par value | holding | — | — | — | 296,902 | D | ||
| Common Stock, no par value | holding | — | — | — | 75,345 | I | By Greenbelt Corp. | |
| Common Stock, no par value | holding | — | — | — | 18,767 | I | By Greenway Partners, LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $3.06 | Feb 16, 2016 | A | 50,000 | A | — | Feb 15, 2026 | Common Stock | 50,000 | 50,000 | D |
| Option to Purchase Common StockF2 | $2.20 | holding | — | — | — | — | Jan 8, 2025 | Common Stock | 75,000 | 75,000 | D |
| Option to Purchase Common StockF3 | $1.34 | holding | — | — | — | — | Dec 28, 2020 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant.
- F2One quarter of these options vested on January 8, 2016, and the balance shall vest in 36 monthly installments commencing on the first anniversary of the date of grant.
- F31/48th of the number of options vested and became exercisable at the end of each full month after the date of grant on December 29, 2010.